Csolnoky Ferenc Korhaz
About Csolnoky Ferenc Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Shire
5
Boehringer Ingelheim
3
Janssen Research & Development, LLC
2
Pfizer
2
Société des Produits Nestlé (SPN)
2
Basilea Pharmaceutica
1
Eli Lilly and Company
1
Fresenius Kabi
1
Genentech, Inc.
1
Infant Bacterial Therapeutics
1
Clinical Trials at Csolnoky Ferenc Korhaz
During the past decade, Csolnoky Ferenc Korhaz conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 17 clinical trials were completed, i.e. on
average, 89.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 8 clinical trials were completed. i.e. 800%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
2004-11-01
2006-05-01
Completed
6,635
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
2011-02-01
2014-10-01
Completed
225
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer
2011-07-01
2014-12-01
Completed
882
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis
2013-09-01
2014-09-01
Completed
143
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Csolnoky Ferenc Korhaz" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Shire" with 5 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Pfizer"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Csolnoky Ferenc Korhaz"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "IQVIA Commercial GmbH & Co. OHG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Csolnoky Ferenc Korhaz
According to Clinical.Site data, the most researched conditions in "Csolnoky Ferenc Korhaz" are
"Ulcerative Colitis" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "Respiratory Syncytial Virus Infections" (2 trials). Many other conditions were trialed in "Csolnoky Ferenc Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Csolnoky Ferenc Korhaz
Most popular intervention types in "Csolnoky Ferenc Korhaz" are "Drug" (23 trials), "Other" (9 trials), "Biological" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "BI 695501" (2 trials), "Chemotherapy" (2 trials), "Ontamalimab" (2 trials) and "PVP-I 0.6%" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Csolnoky Ferenc Korhaz
The vast majority of trials in "Csolnoky Ferenc Korhaz" are
29 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Csolnoky Ferenc Korhaz
Currently, there are NaN active trials in "Csolnoky Ferenc Korhaz".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in Csolnoky Ferenc Korhaz,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Csolnoky Ferenc Korhaz, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".